Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.16% | 1,024.80% | -59.91% | -73.13% | -70.90% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.03% | -24.72% | 159.18% | -80.07% | -18.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -69.03% | 310.59% | -5.61% | -75.26% | -63.73% |
|
|
|||||
| Total Current Assets | -69.03% | 310.59% | -5.61% | -75.26% | -63.73% |
| Net Property, Plant & Equipment | -15.00% | -13.04% | -8.00% | -10.71% | -17.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -68.96% | 308.69% | -5.63% | -75.15% | -63.69% |
|
|
|||||
| Total Accounts Payable | -9.35% | 8.43% | 58.77% | 9.61% | 34.71% |
| Total Accrued Expenses | 19.81% | 27.54% | 20.96% | 10.22% | 12.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -42.29% | -36.04% | -- | -- | -- |
| Total Other Current Liabilities | -42.29% | -36.04% | -- | -- | -- |
| Total Current Liabilities | 18.13% | 24.94% | 25.93% | 10.21% | 4.53% |
|
|
|||||
| Total Current Liabilities | 18.13% | 24.94% | 25.93% | 10.21% | 4.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.13% | 24.94% | 25.93% | 10.21% | 4.53% |
|
|
|||||
| Common Stock & APIC | 0.15% | 4.39% | 1.54% | 0.18% | 0.21% |
| Retained Earnings | -4.71% | -4.62% | -3.37% | -3.84% | -7.20% |
| Treasury Stock & Other | 260.93% | 61.18% | -1,340.74% | 77.50% | 82.56% |
| Total Common Equity | -36.06% | -5.83% | -19.26% | -48.83% | -597.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.06% | -5.83% | -19.26% | -48.83% | -597.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -38.00% | -53.25% | -- | -- | -- |
| Total Equity | -36.25% | -9.17% | -28.31% | -48.83% | -597.27% |
|
|
|||||